Le Lézard
Classified in: Health
Subjects: PDT, TDS

Qfix® Launches New Radiotherapy Positioning Technology for the More Precise Treatment of Breast Cancer


AVONDALE, Pa., Sept. 23, 2017 /PRNewswire/ -- Today, Qfix announced the release of the first-in-its-class kVuetm Access 360tm G2 and Accesstm Prone G2 positioning devices that promise to improve prone breast cancer treatment by significantly reducing radiation dose to healthy tissue while improving patient comfort and reproducible positioning.

By allowing breast tissue to fall away from the chest wall as patients lay face down, prone positioning can reduce radiation exposure to the heart and lungs by as much as 90%.1 Prone positioning can also improve the uniformity of dose delivery as well as treatment accuracy by reducing respiratory motion.2

The open design of the kVue Access 360 G2 and Access Prone G2 devices enhances prone breast cancer treatment through precise patient positioning and open access for greater flexibility in treatment planning. Both devices connect to the couch top of the radiotherapy machine and allow gravity to pull the breast away from the chest wall, sparing healthy tissue and creating a uniform shape that enables a more even dose distribution and improved cosmetic outcomes. Compared to other approaches that achieved successful cosmetic outcomes in 60-70% of cases, prone breast treatment with Qfix's positioning technology resulted in successful cosmetic outcomes in 80-90% of the cases.1

Qfix's kVue Access 360 G2 is designed to allow breast cancer treatment for both the left and right breast. This one-of-a-kind positioning solution inserts directly onto the couch top. The absence of a conventional couch top below the insert eliminates scatter and skin dose. The kVue Access 360 G2 also includes an expanded supraclavicular grid, which provides full access to treat the supraclavicular nodes in one set-up.

The Access Prone G2 device is CT and MR compatible to guide patients seamlessly from simulation through treatment. Foam padding increases patient comfort and removable inserts can be positioned for either left or right breast treatment. These inserts also feature low electron generating technology, minimizing skin dose and redefining the gold standard for low attenuating devices. The Access Prone G2 will be featured in the "Postlumpectomy Breast Irradiation in the Prone Position" course to be presented by Julia White, M.D., FACR, FASTRO, and Tina LaPaglia, B.S.R.T., R.T.(R)(T), during the 41st American Society of Radiologic Technologists (ASRT) Radiation Therapy Conference, Tuesday, September 26th, from 10:10-11:10 a.m. in the Novice Room at the Manchester Grand Hyatt in San Diego, CA. 

The new kVue Access 360 G2 and Access Prone G2 devices will be on display with live demonstrations in the Qfix booth #735 during the American Society for Radiation Oncology (ASTRO) annual meeting, September 24 ? 26, 2017, at the San Diego Convention Center.

About Qfix
Qfix (www.Qfix.com) is a world leader in radiotherapy dedicated to helping medical professionals provide the best patient care with the world's finest positioning devices to enhance the probability of positive patient outcomes. For more information, visit www.Qfix.com.

SOURCE: Qfix

1. Santos, Isaura. "Breast Cancer Radiation Therapy In Prone Position Reduces Toxic Side Effects." Radiation Therapy News (2014). https://radiationtherapynews.com/2014/10/16/breast-cancer-radiation-therapy-prone-position-reduces-toxic-side-effects/

2. Buijsen, Jeroen, et al. "Prone Breast Irradiation for Pendulous Breasts." Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 82.3 (2007): 337-40. Print; Croog, Victoria J., et al. "Accelerated Whole Breast Irradiation with Intensity-Modulated Radiotherapy to the Prone Breast." IJROBP 73.1 (2009): 88-93. Print; DeWyngaert, J. Keith, et al. "Accelerated Intensity-Modulated Radiotherapy to Breast in Prone Position: Dosimetric Results." IJROBP 68.4 (2007): 1251-59. Print.

 

SOURCE Qfix


These press releases may also interest you

at 09:48
Perspire Sauna Studio, one of the country's largest sauna franchises specializing in full spectrum infrared (IR) and red-light therapy (RLT), is rolling out a new sauna design and member experience through the brand's long-standing partnership with...

at 09:38
The Kinetix Group (TKG) and Pfizer Inflammation and Immunology received a PM360 Pharma Choice Award for their recent health equity initiative. The award recognized Pfizer's atopic dermatitis interactive guide for varying skin tones....

at 09:37
Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, today announced it has been granted a new Class III certificate by the National...

at 09:15
101 Mobility® is thrilled to announce the opening of its newest location in Eden Prairie, marking the introduction of the city's first nationally branded full-service provider of a wide range of mobility equipment. This includes stair lifts, ramps,...

at 09:15
Vibrant Wellness, a leader in specialized diagnostics and personalized health tools, announced today that its Tickborne Testing received approval from The Wadsworth Center, part of the New York State Department of Health.This approval enables Vibrant...

at 09:07
Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the...



News published on and distributed by: